Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06208735
Title CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries CAN


No variant requirements are available.